FDA Drug Application (019813) for DURAGESIC-25 by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number019813
Product Number004
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage25MCG/HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDURAGESIC-25
Active IngredientFENTANYL

Active IngredientCount
List of drugs with Active Ingredient FENTANYL15


Back to FDA Applications sponsored by JANSSEN PHARMS